(Q24338953)

cellular response to toxic substance

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ying Xia

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Tao Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jessica Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Dongman Chao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Xiaoping Liao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jianlong Zhao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Guoqiang Wen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

May 2014

0 references

published in

Experimental Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

127-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24613828%20AND%20SRC:MED&resulttype=core&format=json

α-Synuclein oligomers and clinical implications for Parkinson disease

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

delta-, but not mu-, opioid receptor stabilizes K(+) homeostasis by reducing Ca(2+) influx in the cortex during acute hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Parkinsonism and personality changes following an acute hypoxic insult during mountaineering.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Neurochemical findings in the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Oxygen and glucose deprivation (OGD)-induced spreading depression in the Substantia Nigra.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Mu-opioid receptor and CREB activation are required for nicotine reward

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Mitochondrial dysfunction and oxidative stress in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Conformation-dependent antibodies target diseases of protein misfolding

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Acute delta-opioid receptor activation induces CREB phosphorylation in NG108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

MPTP: insights into parkinsonian neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Function and regulation of CREB family transcription factors in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Proteomic analysis of hypoxia/ischemia-induced alteration of cortical development and dopamine neurotransmission in neonatal rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Induction of Parkinson disease-related proteins in motor neurons after transient spinal cord ischemia in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

The many faces of α-synuclein: from structure and toxicity to therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Cortical delta-opioid receptors potentiate K+ homeostasis during anoxia and oxygen-glucose deprivation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Mitochondrial biology and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+ -induced neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Forebrain ischemia triggers GABAergic system degeneration in substantia nigra at chronic stages in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Cerebrovascular disease pathology and parkinsonian signs in old age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021

The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPNEUROL.2014.02.022

7 January 2021